EUVIMEDEUVIMED entdecken
Crossref

NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model

Weam W Ibrahim, Krystyna Skalicka-Woźniak, Barbara Budzyńska, Nesrine S El Sayed

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Weam W Ibrahim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: weam.wadie@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Alzheimer Disease, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation mediated by microglia activation is a critical contributor to Alzheimer's disease (AD) pathogenesis. Dysregulated microglia polarization in terms of M1 overactivation with M2 inhibition is involved in AD pathological damage. Scoparone (SCO), a coumarin derivative, displays several beneficial pharmacological effects including anti-inflammatory and anti-apoptotic properties, however, its neurological effect in AD is still elusive. This study investigated the neuroprotective potential of SCO in AD animal model focusing on determining its effect on M1/M2 microglia polarization and exploring the plausible mechanism involved via investigating its modulatory role on TLR4/MyD88/NF-κB and NLRP3 inflammasome. Sixty female Wistar rats were randomly allocated into four groups. Two groups were sham-operated and treated or untreated with SCO, and the other two groups were subjected to bilateral ovariectomy (OVX) and received D-galactose (D-Gal; 150 mg/kg/day, i.p) alone or with SCO (12.5 mg/kg/day, i.p) for 6 weeks. SCO improved memory functions of OVX/D-Gal rats in the Morris water maze and novel object recognition tests. It also reduced the hippocampal burden of amyloid-β42 and p-Tau, additionally, the hippocampal histopathological architecture was prominently preserved. SCO inhibited the gene expression of TLR4, MyD88, TRAF-6, and TAK-1, additionally, p-JNK and NF-κBp65 levels were significantly curbed. This was associated with repression of NLRP3 inflammasome along with M1-to-M2 microglia polarization shifting as exemplified by mitigating pro-inflammatory M1 marker (CD86) and elevating M2 neuroprotective marker (CD163). Therefore, SCO could promote microglia transition towards M2 through switching off TLR4/MyD88/TRAF-6/TAK-1/NF-κB axis and inhibiting NLRP3 pathway, with consequent mitigation of neuroinflammation and neurodegeneration in OVX/D-Gal AD model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAnimalsFemaleHumansRatsCoumarinsGalactoseMicrogliaMyeloid Differentiation Factor 88Neuroinflammatory DiseasesNF-kappa BOvariectomyRats, WistarSignal TransductionToll-Like Receptor 4

Stichwörter der Autor:innen

Alzheimer's diseaseMicroglia polarizationNLRP3 inflammasomeScoparoneTLR4/MyD88 signaling

Substanzen

CoumarinsGalactoseInflammasomesMyeloid Differentiation Factor 88NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratscoparoneTlr4 protein, ratToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: weam.wadie@pharma.cu.edu.eg.
  • Department of Natural Products Chemistry, Medical University of Lublin, Lublin, Poland.
  • Independent Laboratory of Behavioral Studies, Medical University of Lublin, Lublin, Poland.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Ibrahim, W. W., Skalicka-Woźniak, K., Budzyńska, B., & El Sayed, N. S. (2023). NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110239

Vancouver

Ibrahim WW, Skalicka-Woźniak K, Budzyńska B, El Sayed NS. NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110239

BibTeX
@article{Ibrahim2023,
  author = {Ibrahim, Weam W and Skalicka-Woźniak, Krystyna and Budzyńska, Barbara and El Sayed, Nesrine S},
  title = {NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110239}
}
Kostenlos starten →